BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17448503)

  • 1. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
    Chou CC; Yung BY; Hsu CY
    Life Sci; 2007 May; 80(22):2051-9. PubMed ID: 17448503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of nucleophosmin/B23 in TPA-induced megakaryocytic differentiation of K562 cells.
    Hsu CY; Yung BY
    Br J Cancer; 2003 Oct; 89(7):1320-6. PubMed ID: 14520467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ROS and MAPK in TPA-induced ICAM-1 expression in the myeloid ML-1 cell line.
    Traore K; Sharma RB; Burek CL; Trush MA
    J Cell Biochem; 2007 Mar; 100(4):1010-21. PubMed ID: 17131377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis.
    Jacquel A; Herrant M; Defamie V; Belhacene N; Colosetti P; Marchetti S; Legros L; Deckert M; Mari B; Cassuto JP; Hofman P; Auberger P
    Oncogene; 2006 Feb; 25(5):781-94. PubMed ID: 16186797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells.
    Jin UH; Ha KT; Kim KW; Chang YC; Lee YC; Ko JH; Kim CH
    Biochim Biophys Acta; 2008 May; 1780(5):757-63. PubMed ID: 18339327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells.
    Lee CH; Yun HJ; Kang HS; Kim HD
    IUBMB Life; 1999 Dec; 48(6):585-91. PubMed ID: 10683762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
    Shelly C; Petruzzelli L; Herrera R
    Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
    Kim KW; Kim SH; Lee EY; Kim ND; Kang HS; Kim HD; Chung BS; Kang CD
    J Biol Chem; 2001 Apr; 276(16):13186-91. PubMed ID: 11278385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells.
    Chou CC; Hsu CY
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):1-9. PubMed ID: 18758751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of p21(WAF1/CIP1) leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1.
    Sugibayashi R; Shimizu T; Suzuki T; Yamamoto N; Hamada H; Takeda K
    Oncogene; 2001 Mar; 20(10):1220-8. PubMed ID: 11313866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells.
    Hong Y; Martin JF; Vainchenker W; Erusalimsky JD
    Blood; 1996 Jan; 87(1):123-31. PubMed ID: 8547633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation.
    Lerga A; Crespo P; Berciano M; Delgado MD; Cañelles M; Calés C; Richard C; Ceballos E; Gutierrez P; Ajenjo N; Gutkind S; León J
    Cell Growth Differ; 1999 Sep; 10(9):639-54. PubMed ID: 10511314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells.
    Yen A; Varvayanis S; Platko JD
    Cancer Res; 1993 Jul; 53(13):3085-91. PubMed ID: 8363661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of human NDR gene in megakaryocytic differentiation of erythroleukemia K562 cells.
    Liu CC; Chou YL; Ch'ang LY
    J Biomed Sci; 2004; 11(1):104-16. PubMed ID: 14730214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.
    Matsumoto E; Hatanaka M; Bohgaki M; Maeda S
    Kobe J Med Sci; 2006; 52(6):181-94. PubMed ID: 17329956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway.
    Liu JF; Crépin M; Liu JM; Barritault D; Ledoux D
    Biochem Biophys Res Commun; 2002 May; 293(4):1174-82. PubMed ID: 12054499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells.
    Chang YI; Hua WK; Yao CL; Hwang SM; Hung YC; Kuan CJ; Leou JS; Lin WJ
    J Biol Chem; 2010 Jul; 285(27):20595-606. PubMed ID: 20442406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells.
    Racke FK; Lewandowska K; Goueli S; Goldfarb AN
    J Biol Chem; 1997 Sep; 272(37):23366-70. PubMed ID: 9287350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling mechanism of PMA-induced differentiation of K562 cells.
    Kang CD; Lee BK; Kim KW; Kim CM; Kim SH; Chung BS
    Biochem Biophys Res Commun; 1996 Apr; 221(1):95-100. PubMed ID: 8660351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells.
    Pettiford SM; Herbst R
    Leukemia; 2003 Feb; 17(2):366-78. PubMed ID: 12592337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.